Education
About Us
Working with TipRanks
Follow Us
TME Pharma N.V. (DE:0N6A)
:0N6A
Pembrolizumab, Olaptesed Pegol
Metastatic Pancreatic Cancer
Phase II
Not Yet Recruiting
Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer
May 20, 2021
―
Pembrolizumab, Bevacizumab, Temozolomide (Tmz), Radiotherapy, Olaptesed Pegol
Glioblastoma
Phase I/II
Active Not Recruiting
Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
Sep 25, 2019
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does TME Pharma N.V. (0N6A) have in its pipeline
0N6A is currently developing the following drugs: Pembrolizumab, Olaptesed Pegol, Pembrolizumab, Bevacizumab, Temozolomide (Tmz), Radiotherapy, Olaptesed Pegol. These drug candidates are in various stages of clinical development as the company works toward FDA approval.